Ads
related to: keytruda cancer drug- Side Effect Information
Learn More About Potential
Side Effects Here.
- Clinical Trials Results
Access Clinical Trial Results
and Information Here.
- Treatment Tips
Tips to Help You Before
and During Treatment.
- Official Patient Website
Learn About a Treatment Plan
That May Be Right for You.
- Financial Support
Find Information on Financial
Support Programs Here.
- Patient Support
Utilize Patient Resources
to Help You Through Your Journey.
- Side Effect Information
Search results
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 13 hours agoThe study was testing whether a combination of the company’s flagship cancer drug Keytruda and its...
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga via AOL· 13 hours agoKeytruda alone as adjuvant treatment for patients with resected high-risk melanoma (Stage IIB-IV)....
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters via Yahoo News· 19 hours agoThis is the latest setback for the experimental drug, vibostolimab, and the related promising new...
Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study
Market Watch· 18 hours agoMerck & Co. has ended part of a late-stage study of a co-formulation of its blockbuster cancer drug Keytruda in certain skin-
Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint
Morningstar· 5 days agoMerck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with ...
Merck stops skin cancer combination therapy testing in late-stage study
Reuters· 18 hours ago, opens new tab has discontinued testing a combination of an experimental antibody-based drug and...
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoEarlier this month, Merck reported the final analysis findings from the Phase III KEYNOTE-811 trial...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 15 hours agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 5 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 7 days agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
Ads
related to: keytruda cancer drug